Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
folic acid (1 trial)
gerilimzumab (1 trial)
naltrexone (revia) (1 trial)
nimacimab (1 trial)
ryi-018 (1 trial)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Fatty Liver (Phase 1)
Gastroparesis (Phase 2)
Liver Diseases (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 1)
Trials (3 total)
Trial APIs (5 total)